Thierry Guillaudeux
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Erratum to: Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.
Journal: Haematologica
Published: April 01, 2025
Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.
Journal: Frontiers in immunology
Published: January 04, 2024
The Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells.
The Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells.
Journal: Current issues in molecular biology
Published: December 05, 2023
A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.
Journal: Frontiers in immunology
Published: October 10, 2023
Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer.
Journal: PloS one
Published: May 19, 2023
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Journal: Frontiers in oncology
Published: May 18, 2023
Radiosensitizing Fe-Au nanocapsules (hybridosomes®) increase survival of GL261 brain tumor-bearing mice treated by radiotherapy.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 14, 2021
Correction to: Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment.
Journal: BMC cancer
Published: May 20, 2021
Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer.
Journal: Cancers
Published: February 05, 2021
Last Updated: 09/26/2026